Form 4 for SNPS Synopsys
Accepted 2023-12-14 00:00:00 ET · period of report 2023-12-12 · accession 0001517737-23-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-14 | 2023-12-12 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | F - Tax | $567.06 | -1,860 | 26.8K | -6% | -$1.05M |
| D | 2023-12-14 | 2023-12-12 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | A - Grant | $0.00 | +3,750 | 28.6K | +15% | $0 |
| DM | 2023-12-14 | 2023-12-12 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | A - Grant | $0.00 | +7,909 | 3,749 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-12 | F | D | 1,860 | $567.06 | 26,780 | D | — | — | (F2) These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the performance-based restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2023-12-12 | A | A | 3,750 | $0.00 | 28,640 | D | — | — | (F1) Represents 50% of earned stock units of a performance-based restricted stock unit award that was granted on December 2, 2022 for which the Compensation Committee of Synopsys' Board of Directors certified the level of achievement against certain performance goals on December 12, 2023. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-12 | A | A | 3,145 | $0.00 | 3,145 | D | $567.06 · 2024-12-12 to 2030-12-12 | 3,145 Common Stock | (F4) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 4 | Derivative | Restricted Stock Units | 2023-12-12 | A | A | 1,015 | $0.00 | 1,015 | D | $0.00 · 2024-12-08 to 2027-12-08 | 1,015 Common Stock | (F6) 25% of the units vest on the date shown followed by three equal annual installments, subject to continued service through each vesting date. |
| 5 | Derivative | Restricted Stock Units | 2023-12-12 | A | A | 3,749 | $0.00 | 3,749 | D | — · — to — | 3,749 Common Stock | (F7) Each stock unit represents a contingent right to receive one share of Synopsys common stock. (F8) Represents 50% of earned stock units of a performance-based restricted stock unit award that was granted on December 2, 2022 for which the Compensation Committee of Synopsys' Board of Directors certified the level of achievement against certain performance goals on December 12, 2023, which will vest on December 8, 2024 subject to the reporting person's continuous service through such date. (F9) Represents 50% of earned stock units of a performance-based restricted stock unit award that was granted on December 2, 2022 for which the Compensation Committee of Synopsys' Board of Directors certified the level of achievement against certain performance goals on December 12, 2023, which will vest on December 8, 2024 subject to the reporting person's continuous service through such date. |